CTO PCI is often used to treat patients with chronic total occlusion (CTO), or complete blockages of the coronary arteries. Dr James Spratt (London Bridge Hospital, London, UK) argues for the cost-effectiveness and efficacy of percutaneous coronary intervention (PCI) for chronic total occlusion.
1. Which patients should be considered for CTO PCI and which should be referred to surgery?
2. Why is there a debate as to whether CTO PCIs are cost-effective?
3. What is your opinion on this matter?
4. What is needed to silence the naysayers?
Filmed in London at BCIS ACI 2020.
Interviewer: Mirjam Boros
Videographer: Natacha Wienand / Dominic Woodruff